GenKyoTex raises $20.42 million in Series C funding - MarketLine Financial Deals

GenKyoTex raises $20.42 million in Series C funding

GenKyoTex raises $20.42 million in Series C funding - MarketLine Financial Deals
GenKyoTex raises $20.42 million in Series C funding
Published May 24, 2011
4 pages — Published May 24, 2011
Price US$ 20.00  |  Buy this Report Now

About This Report

  
Abstract:

GenKyoTex S.A., a Switzerland-based developer of innovative drugs that block enzymes that produce oxygen radicals, has raised CHF18 million ($20.42 million) in Series C round of venture funding.

  
Source:
Document ID
MA63641_110525
Country
Format:
PDF Adobe Acrobat
Buy Now

MarketLine Financial Deals—MarketLine Financial Deals – Identifying and tracking major financial activity across our full scope of company and sector coverage, MarketLine Financial Deals covers mergers & acquisitions, private equity/venture capital backed buyouts, investments, and exits, IPOs and secondary and follow on offerings, and private placements and exits. Additional non-corporate financial deals including partnership agreements, joint ventures, co-development and research, licensing and co-marketing agreements are also available.

About the Author


Cite this Report

  
MLA:
MarketLine Financial Deals. "GenKyoTex raises $20.42 million in Series C funding" May 24, 2011. Alacra Store. Dec 03, 2016. <http://www.alacrastore.com/storecontent/MarketLine-Financial-Deals/GenKyoTex-raises-20-42-million-in-Series-C-funding-2052-61340>
  
APA:
MarketLine Financial Deals. (2011). GenKyoTex raises $20.42 million in Series C funding May 24, 2011. New York, NY: Alacra Store. Retrieved Dec 03, 2016 from <http://www.alacrastore.com/storecontent/MarketLine-Financial-Deals/GenKyoTex-raises-20-42-million-in-Series-C-funding-2052-61340>
  
US$ 20.00
$  £  
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our MarketLine Financial Deals from one place.